2nd Abu Dhabi Brain Conference 2022 Program Book

www.uaeneurology.com/brainconference2022 #ADBC2022 ABU DHABI H Y B R I D 2nd Prof. Peter Rieckmann, MD, FRCPC, FAAN, FEAN Peter Rieckmann received his medical degree from theUniversity of Göttingen, Germany in 1988. After apostdoctoral fellowship inmolecular immunolo gy at the NIH, Bethesda, USA he completed his training in Neurology at the National Institute for Nervous Disease, London, UK and the University of Göttingen, Germany. Professor Rieckmann received German Board certification in Neurology in 1995. His academic and clinical positions have included Senior (staff) Neurologist and Professor for Neurology, Dept. of Neurology, as well as head of the Clinical Research Group for Multiple Sclerosis and Neuroimmunology, at the Julius-Mximilians University of Würzburg. In 2007 Professor Rieckmann became the Multiple Sclerosis Society of Canada Research Chair and Director of the MS Program and Full Tenured Professor at the University of British Columbia, Vancou ver, Canada. Under his leadership the Vancouver MS clinical research program was awarded Western-Pacific Research and Training Center by the MS Society of Canada. He is a founding member of the EndMS campaign in Canada and was instrumental in establishing the Center for Brain Health at UBC in Vancouver (http://www.centreforbrainhealth.ca ). Prof. Peter Rieckmann Professor of Neurology Director at Center of Clinical Neuroplasticity Medical Park Loipl-Bischofswiesen University of Erlangen Bavaria, Germany Prof. Richard B. Lipton, M.D., is the Edwin S. Lowe Professor and Vice Chair of Neurology, Professor of Epidemiology and Population Health and Professor of Psychiatry and Behav ioral Sciences at the Albert Einstein College of Medicine. Dr. Lipton earned his medical degree at the University Of Chica go Pritzker School Of Medicine. After a medical internship at Northwestern Memorial Hospital, he completed his neurology residency and clinical neurophysiology fellowship at the Albert Einstein College of Medicine. He also completed a fellowship in neuroepidemiology at Columbia University. He is adiplo mate of theAmerican Board of Psychiatry andNeurology and a fellowof theAmericanAcade my of Neurology. His research focuses on cognitive aging, Alzheimer’s disease and migraine headaches. He is the Principal Investigator of the Einstein Aging Study, an NIH funded Program Project, and collaborates onseveral R01s. His research focuseson risk factorsandbiomarkersof cognitivedeclineandAlzhei mer’s disease. His recent studies examine cognitive aging across the lifespan with an emphasis on the effects of pain and stress on brain function. Prof. Dr. Richard B. Lipton Edwin S. Lowe Professor and Vice Chair of Neurology Professor of Epidemiolog and Population Health Professor of Psychiatry and Behavioral Sciences Director, Montefiore Headache Center Director, Division of Cognitive Aging and Dementia Albert Einstein College of Medicine, New York, USA ABOUTOUR EXPERT SPEAKERS Dr. Mir has over 25 years of vast and specialized neurology experience in all fields of neurology, with extensive experience and training in the UK, starting from Hammersmith Hospital London, UK to Leeds General Infirmary Leeds to York Teaching Hospitals in England, which led to Dr. Mir receiving a clinical excellence award in 2015. Dr. Mir also has additional UAE experience with serving SEHA at SKMC and given Adjunct Associate Professor privilege in the college of medicine and Health sciences in UAE and is currently working in Abu Dhabi Stem Cells Center (ADSCC) on a research project for Multiple Sclerosis and Autologous Haematopoietic Stem Cell Therapy for Multiple Sclerosis. Dr. Mir has clinical expertise in Multiple Sclerosis, migraines and headache disorders and general neurology, especially neurological disorders in women. Dr. Ruqqia Mir Consultant Neurologist Neurology Department Sheikh Khalifa Medical City Abu Dhabi, UAE Dr. Salman Aljarallah is an assistant professor of neurology and consultant neurologist and neuroimmunologist at the King Saud University in Riyadh, Saudi Arabia. He graduated from McGill University neurology program before completing a fellowship in Neuroimmunology and neurological infections at Johns Hopkins University. He also serves as the director of the neurol ogy training program at King Saud University. His interest includes multiple sclerosis, neuromyelitis optica and other neuroimmunogical disorders. Dr. Salman Aljarallah Assistant Professor King Saud University Riyadh, KSA